It was almost two years ago that Ian Franks brought you the welcome news that AIMS was a new HSCT charity. Today, he looks further and finds a young but efficient organisation united by a desire to 'put something back'.
HSCT (Autologous Haematopoietic Stem Cell Transplantation) is an effective therapy to fight multiple sclerosis, the level of side effects is acceptable, and the therapy is safe, Ian Franks believes. Now, he answers the question why he has not undergone HSCT himself,
Although I have taken a break from writing during August, I just had to catch up with Paul Morrison who, earlier this month, travelled to Moscow to undergo HSCT for multiple sclerosis. The exact type of the disease is a matter of opinion, his neurologist says Paul has SPMS, but tests in Moscow indicate a … Continue reading Paul pays tribute to dedication of staff as he prepares to leave Moscow HSCT centre
I had planned to take a break from writing this month, August being a slow news month that is well known among journalists as the silly season. That's when minor stories are given major coverage, because of a shortage of stories of real substance. However, I could not let Monday August 6 go unmarked. Why? … Continue reading Paul’s Moscow HSCT for MS journey begins
A new multiple sclerosis charity has appeared in the UK, inspired by one successful HSCT treatment, provided free of charge by the country’s National Health Service (NHS). It is the first charity dedicated to autologous hematopoietic stem cell transplantation (HSCT) for MS patients living in the UK. The treatment was given to James Coates two … Continue reading Charity AIMS to help MS patients to have HSCT
Former Londoner Paul Morrison is seeking support to travel to Moscow to receive hematopoietic stem cell transplantation (HSCT) in August. These days Paul (46) and his family live a stone’s throw from my home in southern Spain. He shares my challenge of living with multiple sclerosis. His dad, Phil, has set up a GoFundMe account, … Continue reading #paulsfighttowalk : Support sought for HSCT in Moscow
At last, interim results of an international study show haematopoietic stem cell transplantation (HSCT) is an effective and safe treatment. It outperforms disease modifying therapies (DMTs) for people with highly-active relapsing MS. Sadly, though, that’s as far as the study goes. Despite there being numerous people with progressive MS who say they have benefited from … Continue reading HSCT ‘safe and effective’ for people with relapsing MS, international study